Associate Professor Anna Hearps
Co-Program Director, Disease Elimination; Head, Infection, Inflammation and Innate Immunity
Working groups
Burnet publications
View 69 moreHeightened monocyte-derived foam cell formation in older men is not explained by inflammatory or oxidized lipid biomarkers
Frontiers in Immunology
Anna C. Hearps et al
Induction of dysfunctional CD14lowCD16- monocytes in acute COVID-19 infection
Frontiers in Immunology
Salimeh Ebrahimnezhaddarzi et al
Characterization of vaginal lactobacilli from South African women toward the development of a biotherapeutic to optimize the vaginal microbiome
Applied and Environmental Microbiology
Jenna Wilson et al
Reports and other work
-
Covid-19 Global Trends and Analysis - Volume 2: SARS-CoV-2 viral load dynamics and infectivity.
Covid-19 Global Trends and Analysis - Volume 2: SARS-CoV-2 viral load dynamics and infectivity.
Current projects
View 10 more
Injecting drug use in Melbourne: SuperMIX cohort study
The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).
Methamphetamine and injecting drug use cohort studies: MIXMAX
MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies: SuperMIX and VMAX.
Immunotherapy-based approaches to cure HIV
The objectives of this project include identifying the relevant NK subset which is the most potent killer of HIV-infected cells and developing anti-HIV antibodies with enhanced function.
News and features
Novel approaches to prevent heart disease
Burnet Co-program Director of Disease Elimination, Associate Professor Anna Hearps and Research Officer Dr Morgane Brunton-O'Sullivan have received a grant from the Heart Foundation to support research on a common cause of heart attacks.
Advancing research through NHMRC grants and scholarships
Congratulations to our researchers on receiving distinguished National Health and Medical Research Council (NHMRC) grants and scholarships.